Search clinical trials for: conbercept

Total 35 results

Jiao Mingfei

Unknown

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Idiopathic Choroidal Neovascularization

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV (SHINY)

Choroid Neovascularization Secondary to Degenerative Myopia

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion (BRAVE)

Macular Edema | Branch Retinal Vein Occlusion

China
Shanghai Eye Disease Prevention and Treatment Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting

Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy

Diabetic Macular Edema

China
Sun Yat-sen University

Unknown

Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma (IVCCCH)

Circumscribed Choroidal Haemangioma

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD) (LAMP)

Very Low Vision Secondary to Wet Age-related Macular Degeneration

China
Tianjin Medical University Eye Hospital

Completed

Intravitreal Conbercept After Vitrectomy

Early Proliferative Diabetic Retinopathy
Chengdu Kanghong Biotech Co., Ltd.

Unknown

The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) (STAR)

Polypoidal Choroidal Vasculopathy (PCV)

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion (FALCON)

Retinal Vein Occlusion

China
Chongqing Medical University

Unknown

Conbercept in Choroidal Neovascularization Secondary to Uveitis

Uveitis | Choroidal Neovascularization
Peking University Third Hospital

Recruiting

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Proliferative Diabetic Retinopathy

China
Ruijin Hospital
Shanghai Municipal Science and Technology Commission

Unknown

PRP vs PRP+IVC for Severe nPDR

Diabetic Retinopathy | Diabete Mellitus | Severe Nonproliferative Diabetic Retinopathy

China
Eye & ENT Hospital of Fudan University

Unknown

Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema | Cataract Diabetic
Xun Xu
Peking University; Zhongshan Ophthalmic Center, Sun Yat-sen University; Air Force... and other collaborators

Unknown

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Age-Related Macular Degeneration | Polypoidal Choroidal Vasculopathy | Pathological Myopia | Conbercept | Pharmacogenomic

China
Chengdu Kanghong Biotech Co., Ltd.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Recruiting

A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma

Retinoblastoma

China
Zhongshan Ophthalmic Center, Sun Yat-sen University

Unknown

Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE) (CONTE)

Diabetes Mellitus, Type 2 | Macular Edema

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy

Polypoid Choroidal Vasculopathy (PCV)

China
Sun Yat-sen University

Unknown

Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma

Circumscribed Choroidal Haemangioma

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (CRAVE)

Central Retinal Vein Occlusion | Macular Edema

China
Ruijin Hospital

Completed

Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy | Tractional Retinal Detachment

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

Diabetic Macular Edema

China
Peking Union Medical College Hospital

Completed

Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

Polypoidal Choroidal Vasculopathy | Conbercept

China
Peking Union Medical College Hospital
Beijing Bethune public welfare fund

Terminated

Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF

Uveitis | Macular Edema | Vascular Endothelial Growth Factor | Effect of Drugs

China
Xiaodong Sun
Shanghai Zhongshan Hospital; Eye & ENT Hospital of Fudan University; Shanghai... and other collaborators

Unknown

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Age-related Macular Degeneration

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization

Corneal Neovascularization

China
Sun Yat-sen University

Unknown

Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy

China
Chengdu Kanghong Biotech Co., Ltd.

Terminated

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Neovascular Age-related Macular Degeneration

United States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
Chengdu Kanghong Biotech Co., Ltd.

Terminated

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)

Neovascular Age-related Macular Degeneration

United States, Bulgaria, China, Czechia, Denmark, France, Hungary, Israel, Italy, Latvia, Slovakia, United Kingdom
Tianjin Medical University Eye Hospital

Recruiting

Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema

Diabetic Macular Edema | Pars Plana Vitrectomy | Conbercept

China
The Eye Hospital of Wenzhou Medical University

Completed

Initial Versus Delayed PDT Combination With Conbercept in PCV

Polypoidal Choroidal Vasculopathy

China
Wenbin Wei

Recruiting

Anti-VEGF in Real-world

Diabetic Macular Edema | Retinal Vein Occlusion | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic Retinopathy | Choroidal Neovascular Membrane | Neovascular Age-related Macular Edema

China
Novartis Pharmaceuticals

Completed

Head to Head Study of Anti-VEGF Treatment. (RELIANCE)

Age-related Macular Degeneration

China
EMD Serono

Terminated

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Arthritis, Psoriatic

United States, Canada
RemeGen Co., Ltd.

Completed

Evaluation of RC28-E Injection in Diabetic Macular Edema

Diabetic Macular Edema

China
Peking University People's Hospital

Completed

Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy

China

Search clinical trials for: conbercept

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations